周 伦,郭 砚

痤疮，作为青少年时期常见的一种皮肤病，其高发病率不仅影响着患者的外貌，更在心理层面和社交生活中投下了深深的阴影。尽管当前存在多样化的治疗手段，但遗憾的是，这些手段往往难以达到患者及医疗人员所期望的完全治愈效果。因此，寻找更为高效、精准的治疗痤疮的作用靶点，成为了当前痤疮治疗领域亟需解决的关键问题。近年来，随着生物信息学和网络技术的飞速发展，基于网络数据库的潜在药物治疗靶点挖掘已成为研究的新热点。本文旨在对现有的痤疮治疗方法进行系统的梳理和总结，并借助网络药理学的理论与方法，深入挖掘并预测痤疮治疗的新靶点。通过这一研究，我们期望能够为未来痤疮治疗药物的研发提供新的方向和思路，为广大痤疮患者带来更为有效的治疗方案。

痤疮；精准化；治疗

[1] RAGEH M A, IBRAHIM S M A, ABDALLAH N, et al. Autologous Nanofat Injection Combined with Fractional CO2 Laser in the Treatment of Atrophic Acne Scars [J]. Clinical Cosmetic and Investigational Dermatology, 2024, 17. [2] JAISWAL S, JAWADE S, MADKE B, et al. Recent Trends in the Management of Acne Vulgaris: A Review Focusing on Clinical Studies in the Last Decade [J]. Cureus, 2024, 16(3): e56596. [3] YANG M, ZHOU M, WANG H, et al. Lipidomics reveals the role of glycoceramide and phosphatidylethanolamine in infantile acne [J]. J Cosmet Dermatol, 2021, 20(3): 947-54. [4] GODíNEZ-CHAPARRO J A, CRUZ H V. [Acne in the newborn.] [J]. Bol Med Hosp Infant Mex, 2021, 78(5): 443-9. [5] SCHACHNER L, ANDRIESSEN A, BENJAMIN L, et al. The Many Faces of Pediatric Acne: How to Tailor Nonprescription Acne Treatment and Skincare Using Cleansers and Moisturizers [J]. J Drugs Dermatol, 2022, 21(6): 602-12. [6] WANG H, WANG J, ZHOU M, et al. Prediction of neonatal acne based on maternal lipidomic profiling [J]. J Cosmet Dermatol, 2020, 19(10): 2759-66. [7] SNYDER K A M, VOELCKERS A D. Newborn Skin: Part I. Common Rashes and Skin Changes [J]. Am Fam Physician, 2024, 109(3): 212-6. [8] ALTUN E, TOPALOGLU DEMIR F. Occupational facial dermatoses related to mask use in healthcare professionals [J]. J Cosmet Dermatol, 2022, 21(6): 2535-41. [9] DARNALL A R, SALL D, BAY C. Types and prevalence of adverse skin reactions associated with prolonged N95 and simple mask usage during the COVID-19 pandemic [J]. J Eur Acad Dermatol Venereol, 2022, 36(10): 1805-10. [10] DANI A, ESEONU A, BIBEE K. Risk factors for the development of acne in healthcare workers during the COVID-19 pandemic [J]. Arch Dermatol Res, 2023, 315(4): 1067-70. [11] GUTIéRREZ-MERé R, TAJES I, DIéGUEZ P, et al. Acne Fulminans: A Narrative Review [J]. Actas Dermosifiliogr, 2023, 114(9): 763-71. [12] DALL'OGLIO F, PUGLISI D F, NASCA M R, et al. Acne fulminans [J]. G Ital Dermatol Venereol, 2020, 155(6): 711-8. [13] GIER H, ISRAELI A, CUSICK A, et al. Use of Interleukin-12/23 Inhibitor for the Management of Acne Fulminans [J]. Cureus, 2023, 15(12): e50352.[14] BARRY K K, NEALE H D, HAWRYLUK E B. Tumor necrosis factor-alpha inhibitors and acne fulminans: Friend or foe? [J]. Pediatr Dermatol, 2023, 40(4): 678-80. [15] MARASCA C, FABBROCINI G, ABATEGIOVANNI L, et al. Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case [J]. Skin Appendage Disord, 2021, 7(2): 115-9. [16] LEGAL K, MISERY L. Isotretinoin-induced Acne Fulminans without Systemic Symptoms Treated Successfully with Oral Dapsone [J]. Acta Derm Venereol, 2020, 100(1): adv00036. [17] AL-HAMDI K I, SAADOON A Q. Acne Conglobata of the Scalp [J]. Int J Trichology, 2020, 12(1): 35-7. [18] HAFSI W, ARNOLD D L, KASSARDJIAN M. Acne Conglobata [M]. StatPearls. Treasure Island (FL); StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC. 2024. [19] KOCEVA I, RüMMELEIN B, GERBER P A, et al. Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa [J]. Clin Case Rep, 2019, 7(9): 1769-72. [20] MIURA S, TSUNODA K, AMANO H. A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor [J]. Dermatol Reports, 2023, 15(3): 9699. [21] LIU S, WU X, CAO Y, et al. Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata [J]. Pediatr Rheumatol Online J, 2022, 20(1): 88. [22] WU Q Y, ZHANG Q, BU W B, et al. A case of 5-aminolevulinic acid photodynamic therapy(ALA-PDT)combined with surgery for the treatment of acne conglobata [J]. Photodiagnosis Photodyn Ther, 2022, 39: 102986. [23] VASAM M, KORUTLA S, BOHARA R A. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances [J]. Biochem Biophys Rep, 2023, 36: 101578. [24] BARCELLONA D, GRANDONE E, MARONGIU F. Hormones and thrombosis: the dark side of the moon [J]. Blood Transfus, 2024, 22(1): 46-54. [25] RAJPUT I, ANJANKAR V P. Side Effects of Treating Acne Vulgaris With Isotretinoin: A Systematic Review [J]. Cureus, 2024, 16(3): e55946. [26] HUANG Y, HUANG Y, XIA D, et al. Lactobacillus rhamnosus ameliorates acne vulgaris in SD rats via changes in gut microbiota and associated tryptophan metabolism [J]. Front Immunol, 2023, 14: 1293048. [27] BOBY A, LEE G, NATARELLI N, et al. Using probiotics to treat acne vulgaris: systematic review [J]. Arch Dermatol Res, 2024, 316(4): 101. [28] BUNGAU A F, RADU A F, BUNGAU S G, et al. Emerging Insights into the Applicability of Essential Oils in the Management of Acne Vulgaris [J]. Molecules, 2023, 28(17). [29] SHIELDS A, LY S, WAFAE B, et al. Safety and Effectiveness of Oral Nutraceuticals for Treating Acne: A Systematic Review [J]. JAMA Dermatol, 2023, 159(12): 1373-82. [30] KIM H J, KIM Y H. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies [J]. Int J Mol Sci, 2024, 25(10). [31] EL-KOMY M H M, ABDO N M K, SHAMMA R N, et al. Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo-controlled study [J]. Exp Dermatol, 2023, 32(10): 1663-73. [32] MAHRAN A, GHAZALLY A, ALI A S, et al. Efficacy and safety of calcipotriol as a potential topical treatment of acne vulgaris: a randomized, controlled, triple blinded, split-face clinical trial [J]. Clin Exp Dermatol, 2024, 49(4): 348-55.

点击下载PDF